Summary

Clinical Trials Support Services Market Growth & Trends

The global clinical trials support services market size is anticipated to reach USD 35.2 billion by 2028, according to the new report of Grand View Research, Inc., expanding at a CAGR of 7.3% over the forecast period. The factors driving market growth include rising demand for drug development that necessitates clinical trials and an increase in the number of CROs.

In the U.S., the biopharmaceutical sector contributes to around 90% of total spending on clinical trials for drugs and equipment. A clinical trial's costs include data management, patient recruiting, site recruitment, and clinical procedure expenditures. Pharmaceutical firms have been gradually expanding their R&D investment in recent years. This was mostly due to a patent cliff in 2012, which resulted from several patent expirations.

The outbreak of COVID-19 is further expected to enhance demand for clinical trial support services throughout the forecast period. The majority of enterprises and businesses across the world are under threat from the rapidly developing risk caused by the spread of the COVID-19 disease. The current pandemic represents a serious threat to the wellbeing of the whole population. A key to effectively fighting COVID-19 lies in clinical research. The current situation across the globe and the need to think of treatment options have additionally prompted the most optimized plan to led clinical trials.

Clinical Trials Support Services Market Report Highlights

• The phase III segment dominated the market with a revenue share of over 53% in 2020. This growth is attributed to the fact that phase III clinical trials are the most expensive ones and involve huge subjects

• The clinical trial site management service segment accounted for the maximum revenue share in 2020. Clinical trial site management services for managing offshore operations have seen tremendous expansion as a result of the trend of clinical trial outsourcing

• The pharmaceutical & biopharmaceutical companies sponsor segment led the market in 2020. The biopharmaceutical industry accounts for around 90% of total spending on clinical trials for medicines and equipment in the U.S.

• North America is set to lead the global market during the forecast years due to the increasing R&D spending, rising demand for medication development, strong governmental efforts, and current projects

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1 Report Scope
1.1 Segment Scope
1.2 Regional Scope
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information Procurement
2.2 Information Or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Approaches Used To Estimate The Market Size
2.4.1.1 Approach 1: Region Wise Market Estimation Using Bottom-Up Approach
2.4.1.2 Approach 2: Parent Market Analysis
2.4.1.3 Approach 3: Commodity Flow
2.4.2 Global Market: Cagr Calculation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.6 List of Secondary Sources
2.7 List of Primary Sources
2.8 List of Abbreviations
Chapter 3 Objectives
3.1 Objective - 1: Understanding the market dynamics
3.2 Objective - 2: Understanding the market estimates and forecasts
3.3 Objective - 3: Understanding the attributes such as strategy framework, competitor categorization
3.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.
Chapter 4 Executive Summary
4.1 Market Outlook
4.2 Segment Outlook
4.2.1 Phase Segment Trends
4.2.2 Service Business Analysis
4.2.3 Sponsor Business Analysis
4.2.4 Regional Business Analysis
4.3 Competitive Insights
Chapter 5 Clinical Trials Support Services Market: Variables, Trends & Scope
5.1 Market Lineage Outlook
5.1.1 Parent Market Outlook
5.1.2 Ancillary Market Outlook
5.2 Penetration & Growth Prospect Mapping
5.3 Market Variable Analysis
5.3.1 Market Driver Analysis
5.3.1.1 Increasing Number Of Cros Providing Services
5.3.1.2 Rising Demand For Clinical Trials In The Emerging Markets
5.3.1.3 High R&D Spending Of Pharmaceutical & Biotechnology Companies
5.3.2 Market Restraint Analysis
5.3.2.1 The Absence Of Medical Infrastructure And Hi-Tech Instruments
5.3.2.2 Lack Of Adequate Regulatory Framework For Conducting Clinical Trials In Some Countries
5.4 Clinical Trials Support Services Market: Analysis Tools
5.4.1 Porter’s Five Forces Analysis
5.4.2 Pestel Analysis
5.4.3 Major Deals & Strategic Alliances Analysis
Chapter 6 Clinical Trials Support Services Market: Phase Segment Analysis
6.1 Clinical Trials Support Services Market: Definition & Scope
6.2 Clinical Trials Support Services Market: Market Share Analysis, 2020 & 2028
6.3 Phase I
6.3.1 Phase I Market, 2016 - 2028 (USD Million)
6.4 Phase II
6.4.1 Phase II Market, 2016 - 2028 (USD Million)
6.5 Phase III
6.5.1 Phase III Market, 2016 - 2028 (USD Million)
6.6 Phase IV
6.6.1 Phase IV Market, 2016 - 2028 (USD Million)
Chapter 7 Clinical Trials Support Services Market: Service Segment Analysis
7.1 Market: Definition & Scope
7.2 Market: Market Share Analysis, 2020 & 2028
7.3 Clinical Trial Site Management
7.3.1 Market, 2016 - 2028 (USD Million)
7.4 Patient Recruitment Management
7.4.1 Market, 2016 - 2028 (USD Million)
7.5 Data Management
7.5.1 Market, 2016 - 2028 (USD Million)
7.6 Administrative Staff
7.6.1 Market, 2016 - 2028 (USD Million)
7.7 IRB
7.7.1 Market, 2016 - 2028 (USD Million)
7.8 Others
7.8.1 Market, 2016 - 2028 (USD Million)
Chapter 8 Clinical Trials Support Services Market: Sponsor Segment Analysis
8.1 Market: Definition & Scope
8.2 Market: Market Share Analysis, 2020 & 2028
8.3 Pharmaceutical & Biopharmaceutical Companies
8.3.1 Market, 2016 - 2028 (USD Million)
8.4 Medical Device Companies
8.4.1 Market, 2016 - 2028 (USD Million)
8.5 Others
8.5.1 Market, 2016 - 2028 (USD Million)
Chapter 9 Clinical Trials Support Services Market: Regional Analysis
9.1 Market: Definition & Scope
9.2 Regional Market Snapshot
9.3 Market: Market Share Analysis, 2020 & 2028
9.4 North America
9.4.1 Market, 2016 - 2028 (USD Million)
9.4.2 The U.S.
9.4.2.1 Market, 2016 - 2028 (USD Million)
9.4.3 Canada
9.4.3.1 Market, 2016 - 2028 (USD Million)
9.5 Europe
9.5.1 Market, 2016 - 2028 (USD Million)
9.5.2 France
9.5.2.1 Market, 2016 - 2028 (USD Million)
9.5.3 The U.K.
9.5.3.1 Market, 2016 - 2028 (USD Million)
9.5.4 Germany
9.5.4.1 Market, 2016 - 2028 (USD Million)
9.5.5 Italy
9.5.5.1 Market, 2016 - 2028 (USD Million)
9.5.6 Spain
9.5.6.1 Market, 2016 - 2028 (USD Million)
9.6 Asia Pacific
9.6.1 Market, 2016 - 2028 (USD Million)
9.6.2 Japan
9.6.2.1 Market, 2016 - 2028 (USD Million)
9.6.3 China
9.6.3.1 Market, 2016 - 2028 (USD Million)
9.6.4 India
9.6.4.1 Market, 2016 - 2028 (USD Million)
9.6.8 South Korea
9.6.8.1 Market, 2016 - 2028 (USD Million)
9.6.11 Thailand
9.6.11.1 Market, 2016 - 2028 (USD Million)
9.7 Latin America
9.7.1 Market, 2016 - 2028 (USD Million)
9.7.2 Brazil
9.7.2.1 Market, 2016 - 2028 (USD Million)
9.7.3 Mexico
9.7.3.1 Market, 2016 - 2028 (USD Million)
9.7.4 Argentina
9.7.4.1 Market, 2016 - 2028 (USD Million)
9.7.5 Colombia
9.7.5.1 Market, 2016 - 2028 (USD Million)
9.8 MEA
9.8.1 Market, 2016 - 2028 (USD Million)
9.8.2 South Africa
9.8.2.1 Market, 2016 - 2028 (USD Million)
9.8.3 Saudi Arabia
9.8.3.1 Market, 2016 - 2028 (USD Million)
9.8.5 UAE
9.8.5.1 Market, 2016 - 2028 (USD Million)
Chapter 10 Company Profiles
10.1 Charles River Laboratories Intl Inc
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Service Benchmarking
10.1.4 Strategic Initiatives
10.2 WuXi AppTec
10.2.1 Company Overview
10.2.2 Service Benchmarking
10.2.3 Strategic Initiatives
10.3 IQVIA
10.3.1 Company Overview
10.3.2 Financial Performance
10.3.3 Service Benchmarking
10.3.4 Strategic Initiatives
10.4 Insight Genetics
10.4.1 Company Overview
10.4.2 Financial Performance
10.4.3 Service Benchmarking
10.4.4 Strategic Initiatives
10.5 Eurofins Scientific SE
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Service Benchmarking
10.5.5.4 Strategic Initiatives
10.6 The Pharmaceutical Product Development LLC
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Service Benchmarking
10.6.4 Strategic Initiatives
10.7 Icon PLC
10.7.1 Company Overview
10.7.2 Financial Performance
10.7.3 Service Benchmarking
10.7.4 Strategic Initiatives
10.8 Laboratory Corp. of America Holdings
10.8.1 Company Overview
10.8.2 Financial Performance
10.8.3 Service Benchmarking
10.9 ALcura
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Service Benchmarking
10.9.4 Strategic Initiatives
10.10 Parexel International
10.10.1 Company Overview
10.10.2 Service Benchmarking
10.10.3 Strategic Initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 Clinical trials support services market: Market segmentation
Table 3 Clinical trials support services market, 2016 - 2028 (USD Million)
Table 4 Clinical trials support services market: Industry trend analysis
Table 5 Clinical trials support services market: PESTEL analysis
Table 6 Clinical trials support services market: Porter’s analysis
Table 7 Key opportunities prioritized
Table 8 Clinical trials support services market revenue shares by phase, 2016 - 2028 (USD Million)
Table 9 Clinical trials support services market revenue shares by service, 2016 - 2028 (USD Million)
Table 10 Clinical trials support services market revenue shares by sponsor, 2016 - 2028 (USD Million)
Table 11 Clinical trials support services market revenue shares by region, 2016 - 2028 (USD Million)
Table 12 North America clinical trials support services market, by region, 2016 - 2028 (USD Million)
Table 13 North America clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 14 North America clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 15 North America clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 16 The U.S. clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 17 The U.S. clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 18 The U.S. clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 19 Canada clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 20 Canada clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 21 Canada clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 22 Europe clinical trials support services market, by region, 2016 - 2028 (USD Million)
Table 23 Europe clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 24 Europe clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 25 Europe clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 26 The U.K. clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 27 The U.K. clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 28 The U.K. clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 29 Germany clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 30 Germany clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 31 Germany clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 32 Spain clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 33 Spain clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 34 Spain clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 35 France clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 36 France clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 37 France clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 38 Italy clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 39 Italy clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 40 Italy clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 41 Asia Pacific clinical trials support services market, by region, 2016 - 2028 (USD Million)
Table 42 Asia Pacific clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 43 Asia Pacific clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 44 Asia Pacific clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 45 China clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 46 China clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 47 China clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 48 India clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 49 India clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 50 India clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 51 Japan clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 52 Japan clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 53 Japan clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 54 Thailand clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 55 Thailand clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 56 Thailand clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 57 South Korea clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 58 South Korea clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 59 South Korea clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 60 Latin America clinical trials support services market, by region, 2016 - 2028 (USD Million)
Table 61 Latin America clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 62 Latin America clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 63 Latin America clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 64 Brazil clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 65 Brazil clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 66 Brazil clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 67 Mexico clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 68 Mexico clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 69 Mexico clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 70 Argentina clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 71 Argentina clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 72 Argentina clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 73 Columbia clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 74 Columbia clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 75 Columbia clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 76 MEA clinical trials support services market, by region, 2016 - 2028 (USD Million)
Table 77 MEA clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 78 MEA clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 79 MEA clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 80 South Africa clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 81 South Africa clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 82 South Africa clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 83 Saudi Arabia clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 84 Saudi Arabia clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 85 Saudi Arabia clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)
Table 86 UAE clinical trials support services market, by phase, 2016 - 2028 (USD Million)
Table 87 UAE clinical trials support services market, by service, 2016 - 2028 (USD Million)
Table 88 UAE clinical trials support services market, by sponsor, 2016 - 2028 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity Flow Analysis
Fig. 8 Clinical trials support services market snapshot (2020)
Fig. 9 Clinical trials support services market segmentation
Fig. 10 Clinical trials support services market: Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Clinical trials support services market: Phase movement analysis
Fig. 19 Clinical trials support services market phase outlook: Segment dashboard
Fig. 20 Clinical trials support services market: Phase movement analysis
Fig. 21 Phase I market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 22 Phase II market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 23 Phase III market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 24 Phase IV market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 25 Clinical trials support services market service outlook: Segment dashboard
Fig. 26 Clinical trials support services market: Service movement analysis
Fig. 27 Clinical trial site management market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 28 Patient recruitment management market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 29 Data management market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 30 Administrative staff market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 31 IRB market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 32 Others market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 33 Clinical trials support services market sponsor outlook: Segment dashboard
Fig. 34 Clinical trials support services market: Sponsor movement analysis
Fig. 35 Pharmaceutical & biopharmaceutical companies market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 36 Medical device companies market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 37 Others market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 Regional market place: Dashboard
Fig. 39 Clinical trials support services market: Definition & Scope
Fig. 40 Regional market snapshot (Figures in USD Billion, 2018)
Fig. 41 Regional outlook, 2020 & 2028
Fig. 42 North America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 43 The U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 44 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 46 France market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 The U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 48 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 Italy market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 50 Spain market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 51 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 52 Japan market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 53 China market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 54 India market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 55 Korea market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 56 Australia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 57 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 58 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 59 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 60 Argentina market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 61 MEA market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 62 South Africa market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 63 Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 64 UAE market estimates and forecast, 2016 - 2028 (USD Million)